Results 231 to 240 of about 34,016,939 (394)

Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma. [PDF]

Sci Rep
Sun D, Duan X, Li N, Qiao O, Hou Y, Ma Z, Liu S, Gong Y, Liu Z.   +8 more
europepmc   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

A Suggested Model for the Measurement of the Impact of Political Risk on Direct Foreign Investment: A General Framework [PDF]

, 1990
Wahid Hamza Hashim, Abdullah Naseer
openalex   +1 more source

A risk model for autonomous marine systems and operation focusing on human–autonomy collaboration

, 2017
Christoph A. Thieme, I. Utne
semanticscholar   +1 more source

Lactylation-related risk model for prognostication and therapeutic responsiveness in uterine corpus endometrial carcinoma. [PDF]

Discov Oncol
Yin Y, Luo M.
europepmc   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Issues in biochemical applications to risk assessment: how do we evaluate individual components of multistage models?

, 1987
M W Anderson
openalex   +1 more source

RE. “GENERAL RELATIVE RISK REGRESSION MODELS FOR EPIDEMIOLOGIC STUDIES” [PDF]

, 1990
Michel Chavance
openalex   +1 more source

Novel cuproptosis-related lncRNAs risk model to predicting prognosis and guiding immunotherapy for OSCC patients. [PDF]

Discov Oncol
Kong L, Wang C, Lu X, Zhu Q, Song Y, Feng X.   +5 more
europepmc   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source